对患有缺血性脑心血管疾病的患者进行血小板造影指导的抗血小板治疗:系统性审查和元分析
Song He1, Quandan Tan2, Haifeng Shao3
1Department of Neurology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, China, hesongsomething@outlook.com.
Cerebrovascular diseases (Basel, Switzerland)
|July 4, 2024
概括
血小板结晶学 (TEG) 引导的抗血小板治疗显著降低了缺血性中风或冠状动脉疾病患者的缺血和出血事件. 与标准治疗相比,这种方法提供了更好的疗效和安全性.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 血液学 血液学 血液学
背景情况:
- 对脑心血管疾病的血小板抑制疗法 (TEG) 导向血小板抑制疗法的有效性尚不清楚.
- 本系统性审查评估了TEG导向治疗与缺血性中风 (IS) 和冠状动脉疾病 (CAD) 患者的标准治疗.
研究的目的:
- 评估TEG导向抗血小板治疗的疗效和安全性.
- 在IS或CAD患者中,将TEG引导治疗与标准抗血小板治疗进行比较.
主要方法:
- 随机对照试验 (RCT) 和观察性研究的系统审查和元分析.
- 包括10项研究 (4项RCT,6项观察性) 涉及1678名患者.
- 主要结局:缺血和出血事件的组合;次要结局:缺血事件,出血事件.
主要成果:
- 在RCT (OR:0.45) 和聚合分析 (OR:0.26) 中,TEG导向治疗显著减少了复合性缺血和出血事件.
- 综合分析显示,TEG导向治疗显著减少了缺血事件 (OR:0.28) 和出血事件 (OR:0.31).
- 所有结果都显示出高统计意义 (p < 0.002).
结论:
- 用TEG引导的抗血小板治疗对IS或CAD患者有效且安全.
- 研究结果支持使用TEG来个性化针对脑心血管疾病的抗血小板治疗.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
514
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
514
Anticoagulant Drugs: Low-Molecular-Weight Heparins
672
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
672


